Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 754 evidences · page 9 / 71

73,3 %Sensitivity for the detection of all stages of diabetic retinopathy using the smartphone-based retinal camera was 73.3%.

Cameroundiabetic retinopathypublié 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument de 16 observations

1,1 %The age-adjusted prevalence of undiagnosed type 2 diabetes in Cameroon was 1.1%.

Cameroundiabète de type 2publié 2011The British journal of nutritioneurope_pmcdocument de 5 observationsDOI 10.1017/s0007114510003399

7,1 %Enterococcus spp. accounted for 7.1% of isolated germs.

Camerounpied diabétiquepublié 2022The Pan African medical journaleurope_pmcdocument de 25 observations

28,7 %The prevalence of hypertension was 28.7% among women in the rural Fulani population of Cameroon aged ≥ 20 years.

Camerounhypertension artérielleobservé 2013publié 2017Journal of health, population, and nutritioneurope_pmcdocument de 3 observationsDOI 10.1186/s41043-017-0112-2

88 patientsA cohort of patients of sub-Saharan African origin included 88 patients with type 2 diabetes.

Cameroundiabète de type 2publié 2004Diabeteseurope_pmcdocument de 8 observationsDOI 10.2337/diabetes.53.3.645

29 %Cerebral toxoplasmosis was associated with inpatient mortality of 29% in a small cross-sectional study from Cameroon.

Camerouncerebral toxoplasmosisHAL · Unilimdocument de 205 observations

16,4 %The prevalence of Cornell product left ventricular hypertrophy among type 2 diabetes patients in Cameroon was 16.4%.

CamerounCornell product left ventricular hypertrophy · diabète de type 2publié 2012Cardiovascular journal of Africaeurope_pmcdocument de 11 observations

6,5 mmol/LThe optimal cut-point to diagnose NICE-diagnosed GDM was 6.5 mmol/L for random plasma glucose (RPG) with a c-statistic of 0.61.

Cameroundiabète gestationnelpublié 2023Frontiers in clinical diabetes and healthcareeurope_pmcdocument de 9 observationsDOI 10.3389/fcdhc.2023.1272333

1 300 000 casesIn 2017, there were 1.3 million incident cases of prostate cancer in men.

Camerouncancer de la prostateobservé 2017publié 2019JAMA oncologyeurope_pmcdocument de 25 observationsDOI 10.1001/jamaoncol.2019.2996

4 %The prevalence of the 233F/V substitution in protease sequences was 4% (2/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

51,3 %Overall age-standardized SARS-CoV-2 IgG seroprevalence in Yaoundé, Cameroon was 51.3% during April 24–May 19, 2021.

CamerounCOVID-19observé April 24–May 19, 2021publié 2022Emerging infectious diseasesOpenAlexdocument de 2 observationsDOI 10.3201/eid2806.212580

99 %Ninety-nine percent of patients had type 2 diabetes.

Cameroundiabète de type 2publié 2022The Pan African medical journaleurope_pmcdocument de 25 observations

15,9 nmol/LMean serum folate was 15.9 nmol/L.

Camerouncardiometabolic diseasepublié 2021Current developments in nutritioneurope_pmcdocument de 6 observations

32,1 %In 2019, 32.1% of all adolescent deaths were due to communicable, nutritional, or maternal causes.

Camerouncommunicable, nutritional, or maternal causesobservé 2019publié 2021Lancet (London, England)europe_pmcdocument de 13 observations

30 %Prevalence of obesity was more than 30% in boys in the Cook Islands, Nauru, Palau, Niue, and American Samoa in 2016.

Camerounobésitéobservé 2016publié 2017Lancet (London, England)europe_pmcdocument de 12 observations

50 %LLINs from both Bertoua and Eyang failed to reach the 50% mortality threshold required for minimal effectiveness against field-collected Anopheles strains.

CamerounpaludismeHAL · Unilimdocument de 89 observations

0,94 p_valueThere was no difference between baseline and repeated G6PD activity levels during acute hyperglycaemia in ketosis-prone type 2 diabetes patients (P=0.94).

Cameroundiabète de type 2publié 2015Diabetes & metabolismeurope_pmcdocument de 4 observations

876 casesThere were 876 malaria cases among 1480 individuals in Mfou.

CamerounpaludismeHAL · Unilimdocument de 106 observations

33 patientsThe study included 33 insulin-resistant HIV-infected patients.

Camerouninsulin resistance · VIH/sidapublié 2011Nutrientseurope_pmcdocument de 5 observationsDOI 10.3390/nu3070712

52 %The incidence of drug-induced hepatotoxicity (DIH) was 52% among HIV patients in Cameroon.

Cameroundrug-induced hepatotoxicity · VIH/sidaobservé 2018-2019publié 2024BMC infectious diseaseseurope_pmcdocument de 4 observations

28 %According to the National Malaria Control Programme (NMCP) report, approximately 28% of hospital morbidity was due to malaria in 2019.

Camerounpaludismeobservé 2019HAL · Unilimdocument de 106 observations

57,29 %The frequency of multiclonal infections was higher in Tibati (57.29%) than in Mfou (68.9%).

CamerounpaludismeHAL · Unilimdocument de 106 observations

17,7 %GDM prevalence was 17.7% using IADPSG 2010 criteria in a Cameroonian population.

Cameroundiabète gestationnelpublié 2023Frontiers in clinical diabetes and healthcareeurope_pmcdocument de 9 observationsDOI 10.3389/fcdhc.2023.1272333

No symptomatic arrhythmic events occurred during the treatment course.

CamerounCOVID-19observé 2020publié 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument de 6 observationsDOI 10.1101/2020.06.24.20139386

7 %Among adults tested for HIV during the campaign, 588 (7%) tested HIV-positive.

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.